Erratum to combing stereotactic body radiotherapy with checkpoint inhibitors after oligoprogression in advanced non-small cell lung cancer
- PMID: 35399569
- PMCID: PMC8988086
- DOI: 10.21037/tlcr-2022-1
Erratum to combing stereotactic body radiotherapy with checkpoint inhibitors after oligoprogression in advanced non-small cell lung cancer
Abstract
[This corrects the article DOI: 10.21037/tlcr-21-682.].
2022 Translational Lung Cancer Research. All rights reserved.
Erratum for
-
Combing stereotactic body radiotherapy with checkpoint inhibitors after oligoprogression in advanced non-small cell lung cancer.Transl Lung Cancer Res. 2021 Dec;10(12):4368-4379. doi: 10.21037/tlcr-21-682. Transl Lung Cancer Res. 2021. PMID: 35070747 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources